BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3044701)

  • 1. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals.
    Hayes AA; Rose AH; Musk AW; Robinson BW
    Chest; 1988 Sep; 94(3):521-5. PubMed ID: 3044701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor.
    Hayes AA; Venaille TJ; Rose AH; Musk AW; Robinson BW
    Exp Lung Res; 1990; 16(2):121-30. PubMed ID: 2184026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolitis of pulmonary asbestosis. Bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals.
    Robinson BW; Rose AH; James A; Whitaker D; Musk AW
    Chest; 1986 Sep; 90(3):396-402. PubMed ID: 3017641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
    Garcia JG; Griffith DE; Cohen AB; Callahan KS
    Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.
    Schoenberger CI; Hunninghake GW; Kawanami O; Ferrans VJ; Crystal RG
    Thorax; 1982 Nov; 37(11):803-9. PubMed ID: 7163997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure.
    Broser M; Zhang Y; Aston C; Harkin T; Rom WN
    Int Arch Occup Environ Health; 1996; 68(2):109-14. PubMed ID: 8720280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
    Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
    Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos.
    Rom WN; Travis WD
    Chest; 1992 Mar; 101(3):779-86. PubMed ID: 1541147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased alveolar plasminogen activator in early asbestosis.
    Cantin A; Allard C; Bégin R
    Am Rev Respir Dis; 1989 Mar; 139(3):604-9. PubMed ID: 2923358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.
    Rola-Pleszczynski M; Gouin S; Bégin R
    Inflammation; 1984 Mar; 8(1):53-62. PubMed ID: 6715031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis.
    Xaubet A; Rodriguez-Roisín R; Bombí JA; Marín A; Roca J; Agustí-Vidal A
    Am Rev Respir Dis; 1986 May; 133(5):848-54. PubMed ID: 3706896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macrophages in vitro in asbestosis.
    Rom WN; Harkin T
    Environ Res; 1991 Aug; 55(2):145-56. PubMed ID: 1651223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease.
    Schwartz DA; Galvin JR; Merchant RK; Dayton CS; Burmeister LF; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):400-5. PubMed ID: 1736749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage and clearance of 99m-Tc-DTPA in asbestos workers without evidence of asbestosis.
    Gellert AR; Langford JA; Uthayakumar S; Rudd RM
    Br J Dis Chest; 1985 Jul; 79(3):251-7. PubMed ID: 3893510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta.
    Mutsaers SE; Harrison NK; McAnulty RJ; Liao JY; Laurent GJ; Musk AW
    J Pathol; 1998 Jun; 185(2):199-203. PubMed ID: 9713348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophil chemotactic factor in lung injury produced by immune complexes].
    Tanoue M
    Arerugi; 1989 Nov; 38(11):1209-16. PubMed ID: 2697200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vitro exposure to nitrogen dioxide on human alveolar macrophage release of neutrophil chemotactic factor and interleukin-1.
    Pinkston P; Smeglin A; Roberts NJ; Gibb FR; Morrow PE; Utell MJ
    Environ Res; 1988 Oct; 47(1):48-58. PubMed ID: 3049064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannin-mediated secretion of a neutrophil chemotactic factor from alveolar macrophages. Potential contribution to the acute pulmonary inflammatory reaction associated with byssinosis.
    Rohrbach MS; Kreofsky T; Rolstad RA; Russell JA
    Am Rev Respir Dis; 1989 Jan; 139(1):39-45. PubMed ID: 2492174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure].
    Tokuyama T; Yoneda T; Tamura M; Tsukaguchi K; Yoshikawa M; Tou R; Narita N; Kasuga H; Miyazaki R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):193-8. PubMed ID: 8515598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variety of neutrophil chemotactic factors in the respiratory tracts in patients with respiratory diseases].
    Hayashi H; Ozaki T; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):580-6. PubMed ID: 2214401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.